Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Earlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.

Richard Benson and Liz Charal of the Sir Jules Thorn Charitable Trust

The Sir Jules Thorn Charitable Trust supports translational medical research as well as innovation and improvement in the wider healthcare sector. To mark its 50th anniversary in 2014, the Trust awarded a grant of £5 million to establish the Sir Jules Thorn Sleep and Circadian Neuroscience Institute (SCNi).

During their visit, Liz Charal and Richard Benson from the Trust met Professor Russell Foster and members of his research group. They were able to see SCNi space in full use, following the formal opening of the Dorothy Crowfoot Hodgkin Building last November. As part of the visit, we celebrated the recent installation of a new donor plaque and SCNi signage recognising the generous support of the Trust.

Thanks to the support of the Trust, the SCNi team are undertaking fundamental research into the mechanisms that generate and regulate circadian rhythms and sleep. They are translating these discoveries to develop different therapeutics to improve health and well-being across the health spectrum.

 

 

Similar stories

Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections

New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

Oxford receives £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. Our department will play a major role.

New insights gained into how the brain encodes information about the world

Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).